Bio-Gene Technology Ltd Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Unknown, was filed 10 Aug 2026.
Bio-Gene Technology Ltd: what insiders have been doing
Bio-Gene Technology Ltd is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 8 November 2026, 3 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €3,056. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €3,056, the purchase published on 10 August 2026 by Timothy Grogan is the largest of the period. Those buying include 1 senior executive.
With 3 filings in twelve months, the company is in line with the median of 3 filings across the 2,535 companies we follow on the same exchange. Since 2026, the database holds 1 purchase and no sales by insiders of the company.
The most recent open-market purchase was published on 10 August 2026, 90 days ago.
Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- Unknown-22.7%Entry A$0.02 · Close at T+30 A$0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Executives0ASX
- ●Executives0ASX
- ▲Executives5,000 AUD0ASX
3 of 3 declarations
About Bio-Gene Technology Ltd
Bio-Gene Technology Ltd is a company focused on developing biotechnology solutions. It is listed on the XASX market.